Abstract
BackgroundVerinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in clinical development for the treatment of gout and asymptomatic hyperuricemia.ObjectivesThe aim of this study was to evaluate the pharmacokinetics, pharmacodynamics,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have